Advertisement
Singapore markets closed
  • Straits Times Index

    3,323.38
    +0.18 (+0.01%)
     
  • S&P 500

    5,266.95
    -39.09 (-0.74%)
     
  • Dow

    38,441.54
    -411.32 (-1.06%)
     
  • Nasdaq

    16,920.58
    -99.30 (-0.58%)
     
  • Bitcoin USD

    68,231.78
    +428.80 (+0.63%)
     
  • CMC Crypto 200

    1,460.32
    +4.45 (+0.31%)
     
  • FTSE 100

    8,209.69
    +26.62 (+0.33%)
     
  • Gold

    2,364.00
    -0.10 (-0.00%)
     
  • Crude Oil

    78.38
    -0.85 (-1.07%)
     
  • 10-Yr Bond

    4.5680
    -0.0560 (-1.21%)
     
  • Nikkei

    38,054.13
    -502.74 (-1.30%)
     
  • Hang Seng

    18,230.19
    -246.82 (-1.34%)
     
  • FTSE Bursa Malaysia

    1,604.26
    -1.09 (-0.07%)
     
  • Jakarta Composite Index

    7,034.14
    -106.09 (-1.49%)
     
  • PSE Index

    6,371.75
    -39.66 (-0.62%)
     

Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares

On April 1, 2024, CEO Karim Temsamani of Cardlytics Inc (NASDAQ:CDLX), a company specializing in purchase intelligence to make marketing more relevant and measurable, sold 32,718 shares of the company. The transaction was filed with the SEC and can be found in the following SEC Filing.

Over the past year, the insider has sold a total of 325,377 shares of Cardlytics Inc and has not made any purchases of the stock. This recent sale continues a trend observed over the past year, where insider transactions have been predominantly sales. In total, there have been 15 insider sells and only 2 insider buys for the company within the same timeframe.

On the date of the sale, shares of Cardlytics Inc were trading at $13.69, giving the company a market cap of $602.089 million. According to the GuruFocus Value, which is $15.91, Cardlytics Inc has a price-to-GF-Value ratio of 0.86, indicating that the stock is modestly undervalued.

ADVERTISEMENT

The GF Value is a proprietary intrinsic value estimate from GuruFocus, which is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, an adjustment factor based on the company's historical returns and growth, and future business performance estimates provided by Morningstar analysts.

Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares
Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares

The insider trend for Cardlytics Inc suggests that insiders have been more inclined to sell shares than to buy them over the past year, which could be indicative of their perspective on the company's valuation or future prospects.

Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares
Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares

The GF Value chart provides a visual representation of the stock's current price relative to its intrinsic value, as estimated by GuruFocus. With the stock trading below the GF Value, it may be considered an opportunity for investors who believe in the company's fundamentals and are looking for potentially undervalued investments.

Investors and analysts often monitor insider transactions as they can provide insights into how the company's executives and directors view the stock's value and future performance. However, it is important to consider a wide range of factors when evaluating the implications of insider transactions.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.